EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical management of maxillary osteonecrosis associated with antiresorptive medication (MRONJ): Presentation of clinical cases

Eduardo A Rey, Sergio A. Rodriguez Genta, Silvana Noemi Picardo

Journal of Internal Medicine: Science & Art · 2020

DOI: 10.36013/jimsa.v1i1.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine: Science & Art, 2020. Verfasst von Eduardo A Rey und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiresorptive drugs: Bisphosphonates (BPs) and Monoclonal Antibodies: Denosumab (DS) are known to suppress osteoclastic activity, affecting the expression of the RANKL (Kappa β Nuclear Activation Receptor), which corresponds to an osteoblastic differentiation factor and which is secreted by said cells, being responsible for inducing reabsorption by osteoclasts. Under certain circumstances, those medications may induce the development of Maxillary Osteonecrosis (MRONJ).The paper is aimed to share our experience of MRONJ treatment using minimally invasive therapies (including washes and antibiotics) that does not expand the necrotic bed volumetrically and provide non-recurrent resolution of the lesion. The patients we described were on long-term therapy either with BPs or DS.Conclusion: Interaction between health professional is essential for MRONJ prevention. The therapeutics consolidated in non-invasive maneuvers, and the manipulation of bone tissue with close follow up allows to avoid spread to deep planes. The pathological process could be successfully treated, and it is not necessary to suspend antiresorptive medications.

Zitieren

APA

Rey, E. A., Genta, S. A. R., & Picardo, S. N. (2020). Clinical management of maxillary osteonecrosis associated with antiresorptive medication (MRONJ): Presentation of clinical cases. Journal of Internal Medicine: Science & Art. https://doi.org/10.36013/jimsa.v1i1.23

Vancouver

Rey EA, Genta SAR, Picardo SN. Clinical management of maxillary osteonecrosis associated with antiresorptive medication (MRONJ): Presentation of clinical cases. Journal of Internal Medicine: Science & Art. 2020. doi:10.36013/jimsa.v1i1.23

BibTeX
@article{Rey2020,
  author = {Rey, Eduardo A and Genta, Sergio A. Rodriguez and Picardo, Silvana Noemi},
  title = {Clinical management of maxillary osteonecrosis associated with antiresorptive medication (MRONJ): Presentation of clinical cases},
  journal = {Journal of Internal Medicine: Science & Art},
  year = {2020},
  doi = {10.36013/jimsa.v1i1.23}
}
Kostenlos starten →